Plain-English translation of NCT06636734 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether , a medication that lowers cholesterol, combined with , an immunotherapy drug, can work together to fight head and neck cancer. Researchers believe that might help the body's immune system work better when paired with this treatment. The study will enroll 28 people to see if the combination slows cancer growth and improves survival.
Head and neck cancer that comes back or spreads is very hard to treat, and current treatment options have limited success. Researchers hope that combining these two medications might help patients' immune systems fight the cancer more effectively.
You likely qualify if…
You likely don't qualify if…
You would take as a daily pill at home and receive as an intravenous infusion (IV) on day 1 of each 3-week cycle, continuing for up to 12 months. Throughout the study, you'll have regular blood draws and imaging scans (CT, MRI, or PET scans) to monitor how well the treatment is working. After treatment ends, you'll be followed for up to 2 years to track your long-term health and response.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States